In summary, overexpression of UBE2S in HCC is associated with poor prognosis, and UBE2S may promote HCC cell proliferation and migration via the VHL/HIF‐1α and VHL/JAK2/STAT3 signaling pathways. Here, UBE2S is linked to hepatocellular carcinoma.